Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| British Heart Foundation | OTHER |
Not provided
Not provided
Not provided
The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.
70 participants with PAD will be randomised into one of two groups: either wait-list controls (usual care) or heat therapy intervention. The 8 week heat therapy intervention will consist of shoulder depth submersion in a hot tub at ~40°C for three times a week. Time for heating will be graded with aim of ~60 minutes submersion time by the end of the intervention. After 8 weeks the wait-list control group will then enrol onto the heat intervention and heat therapy participants will go back to usual care. The primary outcome measure for the study is improvement in maximum walking distance, pain free walking, and time to onset claudication. This will be measured via a graded exercise test. Secondary outcomes include Quality of life as measured by generic and vascular specific questionnaires (SF-36,VascuQoL and EQ-5D-5L), vascular health measured using ABPI, blood pressure, FMD, PWV, and markers of inflammation, oxidative stress, angiogenesis and vascular remodelling will be assessed from blood samples. All aforementioned outcome measures will be taken at baseline, 8 weeks, and 16 weeks. Physical activity behaviour (measured with an accelerometer) will be monitored 7 days prior to the beginning of the study, 7 days prior heat intervention, and 7 days after heat intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wait-list control | No Intervention | Usual care 8 weeks | |
| Heat Therapy Intervention | Active Comparator | Heat therapy intervention through water submersion in a hot tub at ~40°C. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Heat Therapy Intervention | Other | Heat Therapy Intervention of shoulder depth submersion in a 40°C hot tub. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximum Walking Distance | Maximal walking distance a participant can walk, through a graded treadmill test. | Baseline to 8 weeks to 16 weeks |
| Pain Free Walking Distance | Maximum distance participant can walk without pain (IC) | Baseline to 8 weeks to 16 weeks |
| Time for Onset of Claudication | Amount of time able to walk pain free before reaching claudication | Baseline to 8 weeks to 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| VascuQoL-6 | Quality of life was assessed using the Vascular Quality of Life Questionnaire (VacQoL), a disease-specific instrument comprised of 25 items rated on a 7-point Likert scale. When scored as a mean across items, the VacQoL has a range from 1 to 7, where 1 indicates the poorest quality of life and 7 the best. Alternatively, when summed, the total score ranges from 25 (worst) to 175 (best). |
| Measure | Description | Time Frame |
|---|---|---|
| Intervention feasibility assessed via recruitment rate | The investigators will record the number of eligible participants, as well as the number who enrol onto the study. | through study completion, an average of 1 year |
| Intervention feasibility assessed via protocol adherence |
Inclusion Criteria:
• Aged > 18 years
Exclusion Criteria:
• Walking impairment for a reason other than PAD
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Manchester Metropolitan University | Manchester | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058729 | Peripheral Arterial Disease |
| D007383 | Intermittent Claudication |
| D016491 | Peripheral Vascular Diseases |
| D000084462 | Hyperthermia |
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Randomised wait-list controlled feasibility trial
Not provided
Not provided
Not provided
Not provided
| Baseline to 8 weeks to 16 weeks |
| SF-36 | The Short Form 36 Health Survey Questionnaire (SF-36) is used to indicate the health status of particular populations, to help with service planning and to measure the impact of clinical and social interventions. | Baseline to 8 weeks to 16 weeks |
| EQ-5D-5L | The EQ-5D-5L is a brief, multi-attribute, generic, health status measure composed of 5 questions with Likert response options (descriptive system) and a visual analogue scale. The latter asks patients to rate their own health from 0 to 100 (the worst and best imaginable health, respectively). | Baseline to 8 weeks to 16 weeks |
| Markers of Inflammation | Investigators will compare blood sample measures of TNF-α, CRP, MCP-1, IL-1Ra, IL-4, IL-6, IL-8, IL-10, and eHSP70. | Baseline to 8 weeks to 16 weeks |
| Markers of Vascular Remodelling | Investigators will compare blood sample measures of HIF-1α, VEGF, endothelin-1, MMP-9, MMP-10 and nitrite. | Baseline to 8 weeks to 16 weeks |
| Tissue Oxygenation | Superficial tissue oxygen saturation and muscle oxygen consumption will be measured throughout the protocol by a NIRS probe placed on the skin surface of the medial gastrocnemius on the most affected leg. Measurements will be recorded during the graded treadmill test. | Baseline to 8 weeks to 16 weeks |
| Vascular Ultrasound Imaging | Vascular ultrasound images of the carotid, brachial and superficial femoral artery will be obtained using a high-resolution duplex machine (Terason, Burlington, MA) and subsequently used to calculate wall thickness, changes in arterial blood flow and shear stress. | Baseline to 8 weeks to 16 weeks |
| Flow-Mediated Dilation | Flow-mediated dilation (FMD) of the brachial artery will be measured after 10 min of supine rest via reactive hyperemia in response to transient ischemia of the lower arm according to international guidelines. | Baseline to 8 weeks to 16 weeks |
| Ankle-Brachial Pressure Index | Ankle brachial pressure index (ABPI): ABPI will be determined at rest and following a treadmill test by using standardised methodologies | Baseline to 8 weeks to 16 weeks |
| Blood Pressure | Following a 10-minute period of supine rest in a quiet room, blood pressure will be measured (in duplicate) using an automated sphygmomanometer. | Baseline to 8 weeks to 16 weeks |
| Pulse Wave Velocity and Pulse Wave Analysis | Pulse wave velocity will be measured using central (carotid-femoral) and peripheral (carotid-radial) via a handheld tonometer following standard guidelines. This will be used with a SphygmoCor XCEL. | Baseline to 8 weeks to 16 weeks |
| Physical Activity Levels | Physical activity will be measured using a wrist-worn accelerometer. Physical activity will be monitored for 7 days at a time. This including 7 days pre-trial, 7 days pre heat intervention, 7 days post heat intervention, and 7 days post trial (Dependent on what group randomisation was first). | 7 days prior trial, 7 days prior heat intervention, 7 days after heat intervention, 7 days post trial. |
The investigators will examine adherence on visits to the lab for the heat therapy intervention. I.e. How many sessions were completed throughout the 8 weeks. |
| through study completion, an average of 1 year |
| Intervention acceptability via workshop interviews | Workshop interviews will be held between an investigator and participants who has either completed the intervention, withdrawn or declined participation, to ask questions regarding the intervention protocol. | through study completion, an average of 1 year |
| Intervention feasibility via participant comfort | The investigators will examine participant thermal comfort/discomfort throughout each intervention day. This will be done through recording of time spent in tub and thermal comfort scales. | through study completion, an average of 1 year |
| D002318 |
| Cardiovascular Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001832 | Body Temperature Changes |
| D018882 | Heat Stress Disorders |
| D014947 | Wounds and Injuries |